Insurance companies remain cautious about the Trump administration’s U.S. healthcare coverage plan for weight-loss drugs

CVS Health has refused to participate in the weight-loss drug coverage plan, while UnitedHealth Group expressed skepticism toward the initiative, citing "significant challenges and unresolved issues" in the plan's structure. The government’s plan would require insurers to cover weight-loss medications under the federal Medicare program, which could cost health insurance companies billions of dollars in the first year and may force them to raise premiums for Medicare prescription drug plans. (Bloomberg)